TorreyPines Therapeutics (Nasdaq:TPTX) is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies.

Our goal is to develop versatile small molecule product candidates, each capable of treating a number of acute and chronic diseases and disorders such as migraine, chronic pain, muscle spasticity and rigidity, xerostomia and cognitive disorders.